Atea Pharmaceuticals, Inc. (AVIR) stock

AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30

$4.30+0.09 (+2.14%)

Close on Nov 13, 2026Market cap $344.88MP/E –Yield –

Atea Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Atea Pharmaceuticals's EV/EBITDA was 3.5× on Oct 29, 2021.

Period	Period end	Value	Change (pts)
2021	Oct 29, 2021	3.5×	–

See a number that looks wrong?